For the Quarter Ending December 2022
Over the first half of the fourth quarter, Levocetirizine Di-Hydrochloride's price gradually increased in North America. The pharmaceutical industry's end-user demand kept Levocetirizine Di-Hydrochloride costs on the high end. Additionally, there was a steep decline in supply chain disruption in the six months leading up to November across several measures, including shipping costs, which further bolstered the Levocetirizine Di-Hydrochloride market's upward trend. However, at the beginning of December, they started to fall precipitously due to a major decrease in their offtakes. Prices for Levocetirizine Di-Hydrochloride declined when they were recorded at USD 648000 /MT CFR Los Angeles.
In the fourth quarter of 2022, Levocetirizine Di-Hydrochloride prices in Asia, particularly in China, sharply declined. However, prices remained good throughout the initial half of q4 due to strong downstream demand balanced with supplies among market participants. On the other hand, the ease with which the supply chain was disrupted in November compared to October, including the lower shipping costs, encouraged the traders and suppliers to increase orders and balance the demand side. With the year 2022 concluding, China's production activities started to notably decline after November due to an increase in COVID-19 instances, which caused a decline in trade momentum and a reduction in freight costs, both of which helped the Levocetirizine Di-Hydrochloride price trend. Overall, the Levocetirizine Di-Hydrochloride costs noted in the middle of the fourth were assembled at USD 604500/MT FOB Shanghai in China.
The Levocetirizine Di-Hydrochloride market in Europe followed a similar trajectory to that in Asia Pacific in the fourth quarter of 2022. Due to a rise in demand from the end-user pharmaceutical business, the market trend started off well up until November and reached an assembly price of USD 663990/MT CFR Hamburg in Germany. Until December, Levocetirizine Di-Hydrochloride pricing inquiries from the downstream industry remained sturdy, reinforcing the drug's weaker price trend because market participants had plenty of supply and little demand. Furthermore, fresher orders did not require by traders as suppliers had enough stocks with them to meet any immediate necessities.
For the Quarter Ending September 2022
In the North American region, Levocetirizine Dihydrochloride prices continued to decrease throughout the third quarter of 2022 due to weak demand from the downstream pharmaceutical sector. Additionally, adequate inventories in the domestic market have noticeably propelled Levocetirizine Dihydrochloride market sentiments to be on the lower side. Also, the zero covid policy in China has abrupted the global supply chain and negatively impacted the price trends of Levocetirizine Dihydrochloride in the United States. Trading activity witnessed from India also was on the dull side, which further supported the market sentiments of Levocetirizine Dihydrochloride in the North American region. Furthermore, towards the termination of Q3, the prices witnessed for Levocetirizine Dihydrochloride were settled at USD 147000/ MT CFR Los Angeles.
During the third quarter of 2022, the pricing trend for Levocetirizine Dihydrochloride in the Asia Pacific showed a fainter tendency. Consistent COVID-19 cases and strict lockdown conditions in China during August kept the market of Levocetirizine Dihydrochloride on the weaker side. Further, weak global demand with soaring energy prices declined the overall trading momentum, negatively affecting the pricing sentiments of Levocetirizine Dihydrochloride. Also, owing to fewer buying activities, domestic merchants were left with the stockpiling of downstream products propelling them to reduce the prices to destock their lists. With the ending of Q3, the price of Levocetirizine Dihydrochloride witnessed a decremented trend with the settlement of USD 129900/MT FOB Shanghai.
In the European region, the price of Levocetirizine Dihydrochloride witnessed a negative market sentiment backed by the weaker downstream demand and disrupted trading activities from the exporting countries. The war between Russia and Ukraine has affected the trading tendency throughout the region resulting in slowing commodities flow which negatively impacted the price trend for Levocetirizine in Europe. Throughout the whole Q3 of 2022, demand from end-user pharmaceutical companies remained dull. Overall, the providers had sufficient inventory to meet all domestic demand. Additionally, with the ending of Q3, the market witnessed a decremented trend owing to weaker demand and halted supplies from the APAC region. The prices demonstrated at the end of Q3 were settled at USD 149485/MT CFR Hamburg.
The second quarter of 2022 showcased a declining trend in the prices of Levocetirizine Dihydrochloride in the North American market. The US market remained dull throughout the quarter as the downstream demand recorded were low. There were sufficient stocks with the traders in the market that could further fulfil the overall local demand. Lower fuel prices due to lessened import and export activities decreased freight rates and accumulated shipments which collectively impacted the market and Levocetirizine Dihydrochloride sodium prices in the region overall. Followed with the ending of q2 the price of Levocetirizine Dihydrochloride witnessed in North America region were assessed at USD 153000/MT CFR Los Angeles.
In the Asia-Pacific region, the market prices of Levocetirizine Dihydrochloride remained on the lower edge during the second quarter of 2022. In the Indian market, the prices of Levocetirizine Dihydrochloride witnessed a fall as the manufacturers had enough product available to cater to the firm offtakes of the product from downstream sectors. The demand for antihistamine-producing pharmaceutical drugs remained slow in the Indian market, influencing the market prices. The need for products in China remained sluggish as the country remained silent throughout the quarter owing to the spread of infection. The production cost remained on the lower edge as the API prices remained stagnant. Towards the termination of q2 the prices inclined significantly owing to increased in downstream demand from end-user sectors. overall, the prices witnessed for Levocetirizine Dihydrochloride were settled at USD 122000/MT FOB Shanghai in China.
The European market witnessed a declined trend in the prices of Levocetirizine Dihydrochloride during the second quarter. The demand for antihistamine drugs remained weak in the region leading to low market prices of the product in the regional market. Furthermore, weaken query from customers resulted in a decrease transportation of the API from supplying countries which resulted in stockpiling of inventories at the ports. Weaken demand results in the stockpiled stocks with domestic suppliers due which they reduced the prices to destock their inventories. Also, Weak upstream Crude oil prices, regional demand resulted in the decreased prices of Levocetirizine Dihydrochloride in the market. Altogether, the prices recorded for Levocetirizine Dihydrochloride Di-hydrochloride were settled at USD 166650/MT CFR Hamburg in Germany.